Please find attached herewith Annual Report 24-25.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gian Life Care, a Kanpur-based diagnostic services company, filed its 7th Annual Report for FY 2024-25. Standalone revenue from operations was Rs 663.10 lakhs with a profit after tax of Rs 14.76 lakhs, but on a consolidated basis the company slipped into a loss with a PAT of Rs (4.46) lakhs. The Statutory Auditors flagged three qualifications: IPO proceeds not fully spent on stated objects, Rs 421.99 lakhs in outstanding statutory dues despite a Rs 693.86 lakh cash balance, and several loans classified as Non-Performing Assets (NPAs). The Board admitted the company is going through a 'severe financial crunch.' The Secretarial Auditor also noted multiple delayed filings with BSE, missing E-forms, non-maintenance of the Structured Digital Database for insider trading, and unpaid annual listing fees. No dividend was recommended for the year.
Shareholders should be cautious — the qualified auditor report, NPA status of loans, negative consolidated PAT, and pending statutory dues/fines point to serious financial stress. Compliance lapses and cash being held while dues remain unpaid are red flags that could weigh on the stock and trigger further regulatory penalties.